The results showed that ginsenoside Rh4 could effectively increase the expression of FXR in mice with NAFLD, induce the increase in SHP, and thus downregulate the expression of CYP7A1 protein in the liver. Here, NR0B2 is linked to metabolic dysfunction-associated steatotic liver disease.